This module uses fundamental data of Omni Health to approximate the value of its Beneish M Score. Omni Health M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Omni Health Piotroski F Score and Omni Health Altman Z Score analysis.
As of March 21, 2025, Long Term Debt is expected to decline to about 11.9 K. In addition to that, Short and Long Term Debt is expected to decline to about 1.1 M. At present, Omni Health's Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 6.65, whereas Free Cash Flow Yield is forecasted to decline to (0.02).
At this time, it appears that Omni Health is an unlikely manipulator. The earnings manipulation may begin if Omni Health's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Omni Health executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Omni Health's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Omni Health's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Omni Health's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Omni Health in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Omni Health's degree of accounting gimmicks and manipulations.
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Depreciation
26,517.91
At present, Omni Health's Depreciation is projected to increase significantly based on the last few years of reporting.
About Omni Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omni Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omni Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omni Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Omni Health is a strong investment it is important to analyze Omni Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omni Health's future performance. For an informed investment choice regarding Omni Stock, refer to the following important reports:
For information on how to trade Omni Stock refer to our How to Trade Omni Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omni Health. If investors know Omni will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omni Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
36.608
The market value of Omni Health is measured differently than its book value, which is the value of Omni that is recorded on the company's balance sheet. Investors also form their own opinion of Omni Health's value that differs from its market value or its book value, called intrinsic value, which is Omni Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omni Health's market value can be influenced by many factors that don't directly affect Omni Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omni Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omni Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omni Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.